Early-Onset Invasive Pulmonary Aspergillosis in a Liver Transplant Patient: A Case Report

Juan P Espinosa-Leon1, Theresa Feng1, Andres de Lima1

  • 1Anesthesiology, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.

Cureus
|August 28, 2023
PubMed

Insights

Early invasive pulmonary aspergillosis (IPA) in liver transplant recipients is rare and often fatal. This case highlights the critical need for prompt diagnosis and treatment to combat this deadly fungal infection.

Area of Science:

  • Transplantation Medicine
  • Infectious Diseases
  • Mycology

Background:

  • Invasive pulmonary aspergillosis (IPA) is a rare but highly fatal complication in liver transplant (LT) patients.
  • Early onset of IPA (within 2 weeks post-transplant) presents diagnostic challenges.
  • Managing IPA in LT recipients is complicated by drug interactions between antifungals and immunosuppressants.